Journals / Epilepsi / 2017 / Cilt: 23 - Sayı: 1

Effects of Lacosamide in Cerebral Tuberculoma-Induced Nonconvulsive Status Epilepticus: Case Report

Serebral Tüberküloma Bağlı Nonkonvülzif Status Epileptikusta Lakozamidin Etkisi: Olgu Sunumu

Journal
Epilepsi
Pages
35–40
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Status could be not be controlled with levetiracetam; however, use of lacosamide successfully resolved nonconvulsive status epilepticus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nonconvulsive status epilepticus (NCSE) is characterized by unexplained changes in behavior and mental status accompanied with con-tinuous seizure activity seen on electroencephalography (EEG).
📊
Key Findings & Data:It has high oral bioavailability, is low protein binding and is primarily metabolized by the liver enzyme CYP2C19.
💡
Conclusion & Impact:Status could be not be controlled with levetiracetam; however, use of lacosamide successfully resolved nonconvulsive status epilepticus.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Nonconvulsive status epilepticus (NCSE) is characterized by unexplained changes in behavior and mental status accompanied with con-tinuous seizure activity seen on electroencephalography (EEG). Treatment is similar to treatment of status epilepticus. Lacosamide is one of the newer antiepileptic drugs (AEDs) that slow inactivation of voltage-dependent sodium channels. It has high oral bioavailability, is low protein binding and is primarily metabolized by the liver enzyme CYP2C19. Central nervous system (CNS) tuberculosis may present with signs of parenchymal lesions instead of meningitis. Presently described is a patient who was diagnosed as CNS tuberculosis a year ago with nonconvulsive status epilepticus. Status could be not be controlled with levetiracetam; however, use of lacosamide successfully resolved nonconvulsive status epilepticus.

Özet

Nonkonvülzif status epileptikus (NKSE) davranışlar ve mental durumda açıklanamayan değişiklik, elektroensefalografide (EEG) devamlı nöbet aktivitesinin eşlik ettiği tablodur. Tedavide status epileptikus tedavisi uygulanmaktadır. Lakozamid, voltaja bağımlı sodyum kanallarının yavaş inaktivasyonu ile etki eden, oral biyoyararlanımı yüksek, proteine düşük oranda bağlanan, karaciğerde başlıca CYP2C19 ile metabolize olan yeni antiepileptik ilaçlardan biridir. Merkezi sinir sistemi (MSS) tüberkülozu karşımıza menenjit şeklinde değil de parenkim lezyonları şeklinde çıkabilir. Bu yazıda, bir yıl önce MSS tüberkülozu nedeniyle tanı almış ve tedavi başlanmış olmasına rağmen yeni gelişen nonkonvülzif status kliniği ile başvuran, levetirasetam tedavisine yanıt vermeyen, lakozamid tedavisi altında tam nöbetsizlik sağlanan hasta literatür verileri eşli-ğinde sunuldu.

🔖

Cite This Article

AKDAĞ, G., ALGIN, D. I., ADAPINAR, D. O., ERDİNÇ, O. O. (2017). Effects of Lacosamide in Cerebral Tuberculoma-Induced Nonconvulsive Status Epilepticus: Case Report. Epilepsi, Cilt: 23 - Sayı: 1, 35–40. https://ajindex.com/articles/158359

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Moreno Morales EY, Fernandez Peleteiro M, Bondy Peña EC, Domínguez Lorenzo JM, Pardellas Santiago E, et al. Observatio-nal study of intravenous lacosamide in patients with convulsi-ve versus non-convulsive status epilepticus. Clin Drug Investig 2015
  2. 35(7):463–9. 28. Mnatsakanyan L, Chung JM, Tsimerinov EI, Eliashiv DS. Intrave-nous Lacosamide in refractory nonconvulsive status epilepti-cus. Seizure 2012
  3. 21(3):198–201. 27. Tajender V, Saluja J. INH induced status epilepticus: response to pyridoxine. Indian J Chest Dis Allied Sci 2006
  4. 48(3):205–6. 26. Arman F, Kaya D, Akgün Y, Kocagöz S. Tuberculous meningitis presenting with nonconvulsive status epilepticus. Epilepsy Be-hav 2011
  5. 20(1):111–5. 25. Bahemuka M, Murungi JH. Tuberculosis of the nervous system. A clinical, radiological and pathological study of 39 consecuti-ve cases in Riyadh, Saudi Arabia. J Neurol Sci 1989
  6. 90(1):67–76. 24. Nadirler F, Canbakan Öncül S, Göktay I, Altınbaş H, Başer Y, et al. Progression of Multiple Intracranial Tuberculomas During Tuberculosis Treatment. Türkiye Tıp Dergisi 1997
  7. 319–23. 23. Afghani B, Lieberman JM. Paradoxical enlargement or develop-ment of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994
  8. 19(6):1092–9. 22. Tahaoğlu K, Öğmegül A, Tavlı L, Balcı K. Pons tüberkülomu. Tü-berküloz ve Toraks 1990
  9. 129–32. 21. Kasik JE. Central nervous system tuberculosis. In: Schlossberg D, editor. Tuberculosis and nontuberculosis mycobacterial in-fections. 4th ed. Philadelphia: WB Saunders Company
  10. pp. 175–85. 20. Catena E, De Simone G, Caramoni G, Ciaccia G. Extrapulmonary tuberculosis. Eur Respir Mon 1997
  11. 175–94 19. Iseman MD. Extrapulmonary tuberculosis in adults. In: Iseman MD, editor. A clinician’s guide to tuberculosis. Philadelphia: Lip-pincott Williams Wilkins
  12. pp. 176–92. 18. Sasaki Y, Yamagishi F, Suzuki K, Sugito K, Sugimoto N, Iha-ra S. Asymptomatic multiple intracranial tuberculous no-dules detected in a case of miliary tuberculosis. Kekkaku 1994
  13. 69(6):425–9. 17. Eide FF, Gean AD, So YT. Clinical and radiographic fin-dings in disseminated tuberculosis of the brain. Neurology 1993
  14. 43(7):1427–9. 16. Özge A, Mısırlı H, Erenoğlu NY. Serebral Tüberküloma (Bir olgu nedeniyle). Düşünen Adam Psikiyatri ve Nörolojik Bilimler Der-gisi 1998
  15. 11(1):58–61. 15. Solbrig MV, Healy JF, Jay CA. Infections of the nervous system. In: Bradley WG, Daroff RB, Marsden CD, Fenichel GM, editors. Neurology in clinical practice. 3rd ed. Bosto